LISAvienna: September 2022 e-newsletter available online

Today we include news items published during the summer e.g. by IMBA, Vienna Textile Lab, Lithoz, Valneva, AOP Health, Evercyte, MedUni Vienna, F2G, QUANTRO Therapeutics, Eucodis Bioscience, Boehringer Ingelheim, HOOKIPA Pharma, FFG, Ribbon Biolabs, Biome Diagnostics, usePAT or UpNano. Additional highlights are available in the news section.

In addition, we provide information on funding opportunities and events such as LISAviennna’s 20^th anniversary on September 27, our Regulatory Conference on October 13, or the Austrian booth at BIO-Europe in Leipzig we are in charge of on behalf of the LISA umbrella brand.

Read the newsletter online: https://mailchi.mp/lisavienna/newsletter-september-6-2022
About 3,850 people have subscribed, register at no cost: https://www.lisavienna.at/newsletter/

Do you want LISAvienna to also promote news and events by your Vienna based life sciences company or research institutions? Then add news(at)LISAvienna.at to your mailing list.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.

LISAvienna: September 2022 e-newsletter available online

Uni Vienna: Giant Viruses Infect Deadly Parasite

BMAW: Kocher: Österreich auf dem Weg zur höchsten Forschungsquote in der EU

Österreich investiert 2024 so viel wie nie zuvor in Forschung: Forschungsquote steigt auf 3,34%